Prior to the start of the outbreak in 2007, the notification criteria consisted of a matching clinical presentation and a fourfold titre rise of C. burnetii-specific antibodies, measured in paired samples taken 2 weeks apart, or a positive IgM titre or antibodies against phase I (compatible with chronic Q-fever). The gene discussed is CD40LG; the disease is Q fever.